Archives: Speakers

Viktorija Terebaite is professional in the field of Digital Health, boasting four years of direct experience in integrating digital tools into clinical trials and heading Digital Health Technologies team in Lundbeck. Viktorija has a unique perspective on digital health innovation, having been involved not just in the academic and clinical realms, but also in the commercial technology sector where she worked on a development of a software product used by over 60 million people globally.

As Head of Clinical Vendor Management at UCB, Pierre-Gaultier Delheid leads the vendor strategy aiming to design and manage a strong external vendor network. He makes a point of honor to build sustainable and strong alliances to overcome clinical challenges in a flexibility, agile, reliable, green and cost-efficient way. In close collaboration with other UCB business units, he drives a culture of partnership to change the game to a better outcome.

Engineer by background, his experience in bio-pharma industry in CDMO as well as in Sponsor companies and his business DNA gained during an international EMBA (Hult, US/UK) led him to build strong expertise in the field of operation and business optimization as well as building strong partnerships.

Lindsey Marshall is a Director of Clinical Drug Supply & Logistics at Regeneron Pharmaceuticals. She holds a Master in Clinical Research from Drexel University and has been working in the industry for nearly 20 years. Lindsey currently oversees a team responsible for forecasting, planning, and distribution of clinical drug supply for Regeneron’s portfolio.

Blake Wilson is a Partner in Hogan Lovells’ FDA Regulatory group.  He holds a juris doctorate from the University of Pennsylvania and a master’s degree in biostatistics from Columbia University.  Prior to becoming an attorney he managed Phase I and II pharmaceutical trials at Brown University.  His legal practice focuses on FDA’s premarket approval process for drugs/biologics/devices, oversight of clinical trials including BIMO audits, as well as navigating changes in laws or regulations that govern the life sciences industry.  He also guides sponsors through the special designation programs available at the premarket stage, like RMAT, accelerated approval, and breakthrough.  In this capacity, Blake advises extensively on novel products, study design considerations, and the use of clinical data in FDA-related matters.  By stress testing clinical materials through the lens of an FDA reviewer, Blake helps sponsors avoid pitfalls that can delay or derail a project.

Jason has over 7 years experience in clinical trials. He spent time on both the vendor and sponsor side as a project manager and an IRT manager, respectively. Jason spent the past 3 years as a Manager of Clinical Supply Chain Systems at Apellis Pharmaceuticals. During this time he was also the SME for their supply forecasting tool and spent about one year as a supply manager for a phase 3 trial. Jason is married with two kids, a son who is 4 and a daughter, who is 2. He also has a 12 year old dog.